
Lewy Body Disease, [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, diagnostic imaging [Lewy Body Disease], Europe [MeSH] ; Neuroimaging/methods [MeSH] ; Parkinson Disease/diagnostic imaging [MeSH] ; Biomarkers/metabolism [MeSH] ; Humans [MeSH] ; Editorial ; Lewy Body Disease/diagnostic imaging [MeSH], Parkinson Disease, Neuroimaging, Europe, Editorial, diagnostic imaging [Parkinson Disease], Humans, methods [Neuroimaging], Biomarkers, metabolism [Biomarkers], ddc: ddc:, ddc: ddc:610
Lewy Body Disease, [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, diagnostic imaging [Lewy Body Disease], Europe [MeSH] ; Neuroimaging/methods [MeSH] ; Parkinson Disease/diagnostic imaging [MeSH] ; Biomarkers/metabolism [MeSH] ; Humans [MeSH] ; Editorial ; Lewy Body Disease/diagnostic imaging [MeSH], Parkinson Disease, Neuroimaging, Europe, Editorial, diagnostic imaging [Parkinson Disease], Humans, methods [Neuroimaging], Biomarkers, metabolism [Biomarkers], ddc: ddc:, ddc: ddc:610
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 5 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
